Not Yet Recruiting PHASE4 INTERVENTIONAL 4-arm
NCT06823362
Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions (Pentoxifylline)
Bioequivalence Study of Pentoxifylline 400 Mg in Sustained Release Tablets in Sustained Release Tablets in Healthy Subjects Under Fasting and Fed Conditions
Sponsor: Centro de Atencion e Investigacion Medica
Conditions
Healthy Healthy Donors
Interventions
Pentoxifylline
Updated 1 time since 2025 Last updated: Feb 13, 2025 Started: Apr 10, 2025 Primary completion: Jun 30, 2025 Completion: Sep 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Healthy and Healthy Donors and is currently actively recruiting participants. Centro de Atencion e Investigacion Medica leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Centro de Atencion e Investigacion Medica
Data source: Centro de Atencion e Investigacion Medica
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.